Elham Malekzadeh
Senior Scientist Takeda Pharmaceutical
Seminars
Wednesday 29th April 2026
Validating Organ-on-Chip Models Across Platforms to Enhance Safety Predictions & Translational Accuracy
4:30 pm
- Establishing project-specific validation criteria for organ-on-chip systems to assess translatability against animal studies and clinical outcomes
- Implementing multi-organ approaches including blood, liver, and skin-on-chip models to address diverse safety and efficacy questions
- Standardizing assay protocols across cell therapy and small molecule platforms to ensure reproducible safety hazard predictions
